Increased intermediate monocyte fraction in peripheral blood is associated with nonalcoholic fatty liver disease

Wiener klinische Wochenschrift
Jianmei ZhangFei Jing

Abstract

Nonalcoholic fatty liver disease (NAFLD) currently represents the most common hepatic disease worldwide and is closely linked to cardiovascular disease, obesity and diabetes mellitus. This study aimed to investigate NAFLD and its influence on different monocyte subpopulations to determine the presence of significant associations. A total of 3 monocyte subpopulations were investigated, i.e. classical (CD14++CD16-), intermediate (CD14++CD16+) and non-classical (CD14+CD16++). Of the participants 261 were included in this study (n = 53 with NAFLD, n = 208 controls). Ultrasonography was used to diagnose NAFLD and exclude other morphologic causes of liver diseases and other tests (including medical history inquiries and detection of hepatitis virus) were performed to exclude other causes of parenchymal liver disease. Classical inflammatory and metabolic-related NAFLD biomarkers were also determined. In contrast to the healthy control group, the intermediate monocyte fraction was increased in NAFLD patients (p = 0.032), while the classical monocyte fraction was decreased (p = 0.025). Intermediate monocyte fraction, body mass index (BMI) and tumor necrosis factor alpha (TNF-α) were independent risk factors for NAFLD. Classical, non-cla...Continue Reading

References

Jan 15, 1997·Annals of Internal Medicine·S G ShethS Chopra
Sep 6, 2000·Clinical and Experimental Immunology·K KatayamaS Furukawa
Jun 22, 2002·Journal of Hepatology·Masahiko ShimadaJurgen Ludwig
Aug 21, 2003·The Journal of Dermatology·Hiroyuki OkamotoTakeshi Horio
Jul 23, 2004·Thrombosis and Haemostasis·Axel SchlittHans J Rupprecht
Dec 3, 2005·Nature Reviews. Immunology·Siamon Gordon, Philip R Taylor
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Geoffrey C Farrell, Claire Z Larter
May 15, 2007·Gastroenterology·Steven E ShoelsonAfia Naaz
May 19, 2009·Journal of Hepatology·György Baffy
Mar 16, 2011·The Tohoku Journal of Experimental Medicine·Hack-Lyoung KimDonghee Kim
Sep 29, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Kazushi Sugimoto, Yoshiyuki Takei
May 9, 2012·Journal of Diabetes·Ana C Tuyama, Charissa Y Chang
Apr 16, 2014·International Reviews of Immunology·Kolandaswamy AnbazhaganFlorence Apparailly
Apr 9, 2015·Clinical and Translational Medicine·Brian K Stansfield, David A Ingram
Sep 12, 2015·Scientific Reports·Ratnadeep MukherjeeBalachandran Ravindran
Feb 6, 2016·Reviews in Endocrine & Metabolic Disorders·Marina NatiAntonios Chatzigeorgiou

❮ Previous
Next ❯

Citations

Mar 14, 2019·Metabolic Syndrome and Related Disorders·Konstantinos A ChristouStelios Tigas
Mar 30, 2021·Neuropsychiatric Disease and Treatment·Kai-Qi DingLi-Li Zeng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Current Opinion in Cardiology
Lokpal S BhatiaChristopher D Byrne
Liver International : Official Journal of the International Association for the Study of the Liver
Nathalie C LeiteClaudia R L Cardoso
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Jian-gao FanQian-hong Wo
© 2022 Meta ULC. All rights reserved